SCHEMBL4895785

SCHEMBL4895785

CCc1ccc(S(=O)(=O)N(CC)c2ccc(OCc3ccc(F)cc3)cc2)cc1C(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 4/20 0.49
NFE2L2 Q16236 4/20 0.49
MMP2 P08253 2/20 0.47
MMP9 P14780 2/20 0.47
MAPT P10636 2/20 0.46
LMNA P02545 2/20 0.44
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTPN1 P18031 1/20 0.44
KMT2A Q03164 2/20 0.43
TSHR P16473 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MMP1 P03956 1/20 0.43
MMP14 P50281 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906576 0.93 MMP2 (0.45) KEAP1NFE2L2MMP2MMP9MAPT
SCHEMBL4904702 0.91 LMNA (0.48) KEAP1NFE2L2MAPTLMNAALDH1A1
SCHEMBL4904032 0.91 KEAP1 (0.49) KEAP1NFE2L2MMP2MMP9MAPT
SCHEMBL4907113 0.90 LMNA (0.53) KEAP1NFE2L2MMP2MMP9MAPT
SCHEMBL4904391 0.90 MMP2 (0.49) KEAP1NFE2L2MMP2MMP9MAPT
SCHEMBL4906143 0.89 MAPT (0.49) MAPTLMNAALDH1A1SMN1; SMN2KMT2A
SCHEMBL4904039 0.86 KEAP1 (0.47) KEAP1NFE2L2MMP2MMP9MAPT
SCHEMBL4906945 0.84 LMNA (0.47) KEAP1NFE2L2MAPTLMNAALDH1A1
SCHEMBL4906221 0.83 MMP9 (0.47) KEAP1NFE2L2MMP2MMP9MAPT
SCHEMBL4897482 0.83 LMNA (0.53) KEAP1NFE2L2MMP2MMP9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KEAP1 714/4885NFE2L2 451/4885MMP2 4348/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KEAP1 810/4885NFE2L2 446/4885MMP2 4105/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KEAP1 810/4885NFE2L2 446/4885MMP2 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.